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T cells recognize antigen fragments, presented to them by MHC molecules. It lies in
the interest of the immune system to display a maximal diversity of these peptides and
utilize all catabolic processes to generate them. Macroautophagy, a pathway that deliv-
ers cytoplasmic constituents for lysosomal degradation is no exception. In recent years,
it has become apparent that macroautophagy assists in intra- and extracellular antigen
processing for MHC class II presentation to CD4+ helper T cells. Surprisingly, however,
macroautophagy also assists in antigen packaging for better cross-presentation on MHC
molecules of bystander cells, which could be consistent with its role in unconventional
protein secretion. These three pathways of antigen processing for MHC presentation via
macroautophagy will be discussed in this review and cell biological aspects will be high-
lighted that might explain, how the molecular machinery of macroautophagy might assist
these diverse antigen processing pathways.
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INTRODUCTION
Autophagy describes a group of pathways that deliver cytoplasmic
constituents for lysosomal degradation. Threemain pathways exist
with chaperone-mediated, micro- and macroautophagy (Münz,
2009; Levine et al., 2011; Romao and Münz, 2011; Figure 1). Cur-
rent evidence suggests that mainly macroautophagy can mediate
antigen processing for MHC presentation, while it still remains
unclear if and to which extent the other two pathways might
also contribute (Zhou et al., 2005). Both chaperone-mediated and
microautophagy use cytosolic HSC70 chaperones for substrate
recognition via a pentameric amino acid sequence (Massey et al.,
2006; Sahu et al., 2011). KFERQ as the prototypic sequence in
ribonuclease A and similar motifs that mediate HSC70 binding
have been estimated to occur in 20–35% of all cytosolic pro-
teins (Chiang and Dice, 1988). In the case of chaperone-mediated
autophagy HSC70 links these substrates in a complex of co-
chaperones to Lamp2a in the lysosomal membrane, across which
this cargo then gets imported with the help of an intralysosomal
HSP70 member (Agarraberes et al., 1997). For microautophagy,
HSC70 attaches with its cargo to endosomal membranes and then
buds into these endosomes for multivesicular body (MVB) for-
mation (Sahu et al., 2011). MVB fusion with lysosomes leads then
to degradation of microautophagy cargo. Although chaperone-
mediated and microautophagy target HSC70 substrates to dif-
ferent vesicles, both are restricted to soluble protein delivery for
lysosomal degradation. In contrast, macroautophagy is able to
degrade larger cytoplasmic structures, like protein aggregates and
cell organelles (Yang and Klionsky, 2010a). Depending on the sub-
strate of macroautophagy, xenophagy of intracellular pathogens,
mitophagy formitochondria degradation, ribophagy for ribosome
turnover, and other pathways can be distinguished. In all cases,
however, a cup-shaped isolation membrane forms and engulfs
cytoplasmic constituents to form double membrane surrounded
vesicles, known as autophagosomes. Depending on the location of
the substrate, autophagosomes can form from membranes of ER,
Golgi, plasma membrane, and mitochondria (Tooze and Yoshi-
mori, 2010). For autophagosome formation and their fusion with
lysosomes more than 30 essential gene products of autophagy
related genes (atgs) have now been identiﬁed in yeast, and some
of these are transcriptionally regulated in parallel to lysosomal
constituents (Settembre et al., 2011) or anti-oxidants (Komatsu
et al., 2010; Fujita et al., 2011). I would like to high-light only
ﬁve complexes containing Atgs that are involved in autophago-
some initiation, elongation, and fusion with lysosomes (for a
recent schematic overview see Levine et al., 2011). The ﬁrst is
involved in macroautophagy induced by starvation. It contains
ULK1, 2, or 3, which are the mammalian homologs of the Atg1
serine/threonine kinase, as well as Atg13, FIP200, and Atg101
(Yang and Klionsky, 2010b). Upon starvation the mammalian
target of rapamycin (mTOR) kinase is inhibited, which leads
to dephosphorylation and translocation of the ULK complex to
membranes to initiate autophagosome formation. Although the
direct phosphorylation targets of ULK are still poorly charac-
terized, the ULK complex recruits a second complex, containing
Atg6/Beclin-1 to the site of autophagosome generation. This com-
plex containing also the PI3 kinase VPS34, VPS15, and Atg14
marks the site of autophagosome generation with PI3P deposi-
tion. Atg6/Beclin-1 is normally sequestered from this complex by
the anti-apoptotic Bcl-2 and -xL proteins, but gets released by for
example the AMBRA1 protein to then stimulate macroautophagy.
These PI3P patches recruit the FYVE domain-containing pro-
tein DFCP1, which together with the WIPI1-4 proteins in a third
complex initiates cradle formation for isolation membrane gener-
ation at least at the ER (Hayashi-Nishino et al., 2009; Yla-Anttila
et al., 2009). In these structures, two additional complexes for the
ubiquitin-like proteins Atg8 and Atg12 assist isolation membrane
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FIGURE 1 | Macro-, micro-, and chaperone-mediated autophagy.
Macroautophagy can engulf cytoplasmic material to form autophagosomes,
which then can fuse with multivesicular bodies (MVBs) or directly with
lysosomes. Cytosolic KFERQ-like signal peptide containing proteins may
get transported in an HSC70 dependent fashion into MVBs by
microautophagy, or via docking to Lamp2a and intravesicular HSP70
assisted import into lysosomes. The MVB content might also get degraded
after fusion with lysosomes.
elongation, substrate recruitment, and completion of autophago-
somes. Atg12 is conjugated to Atg5 by the E1- and E2 like enzymes
Atg7 and 10. In complex with Atg16L1 it associates with the outer
autophagosome membrane to form the E3-like enzyme for lipid
ligation of Atg8, which in higher eukaryotes has diversiﬁed into
the family of LC3, GABARAP, and GATE16 proteins. Atg8 is pro-
teolytically processed by Atg4 and then coupled in an E1- (Atg7),
E2- (Atg3), and E3- (Atg12/5/16L1) assisted mechanism to phos-
phatidylethanolamine (PE) in the isolation membrane. Atg8 is
thought to mediate membrane fusion for autophagosome elon-
gation and substrate recruitment into the autophagosome. Once
the autophagosome is completed Atg12/5/16L1 and Atg8 recycle
from the outer autophagosomal membrane and only Atg8 stays
with the inner autophagosomal membrane. Therefore, Atg8 can
be used as a marker to follow autophagosomes. Fusion of these
autophagosomes with lysosomes is then guided by additional
Atg6/Beclin-1 complexes, containing besides Atg6, VPS34, and
VPS15,UVRAG topromote fusionwith lysosomes, andRubicon to
block autophagosome degradation (Liang et al., 2008; Matsunaga
et al., 2009; Zhong et al., 2009). Thus, an elaborate machinery is
involved in autophagosome generation and degradation to deliver
cytoplasmic constituents for lyososomal hydrolysis.
SUBSTRATE RECRUITMENT INTO AUTOPHAGOSOMES
In order to understand, how macroautophagy can contribute
to antigen processing, I have to discuss next which substrates
are recruited to isolation membranes. Although it was originally
assumed that at least during starvation conditions, autophago-
somes would engulf non-selectively cytoplasm, it is now known
that even under these conditions, a clear hierarchy for macroau-
tophagic degradation to generate energy for the starving cell
exists (Kristensen et al., 2008). Namely, proteasomes and pro-
tein aggregates are targeted early during starvation, ribosomes
get degraded in a second wave, and only after prolonged star-
vation mitochondria get engulfed by autophagosomes. But what
are the mechanisms mediating this selectivity? In higher eukary-
otes, there seem to exist two pathways of substrate recruitment
to autophagosomes, both anchoring cytoplasmic constituents to
Atg8/LC3 (Figure 2). The respective anchor proteins contain
a LC3/GABARAP interacting motif (LIR) of four amino acids
(WXXL or WXXI; Kraft et al., 2010). One of these substrate
recruiting pathways and its LIR proteins is evolutionary con-
served down to yeast. For example, Atg32 in yeast and NIX in
higher eukaryotes seem to associate with mitochondria as inte-
gral outer membrane proteins and target them for macroau-
tophagy (Schweers et al., 2007; Sandoval et al., 2008; Kanki et al.,
2009; Okamoto et al., 2009). NIX contains a LIR domain and
recruits GABARAP-L1 onlywhen this LIR domain is intact (Novak
et al., 2010). Thus, organelle speciﬁc proteins can contain a LIR
and mediate recruitment to autophagosomes. In addition, higher
eukaryotes can utilize post-translational protein modiﬁcations to
select macroautophagy substrates. Along these lines, ubiquityla-
tion has been characterized in some detail so far. Aggregates of
poly-ubiquitylated substrates, which are also degraded by protea-
somes, are recruited to autophagosomes (Kirkin et al., 2009b). If
macroautophagy is compromised these aggregates can accumulate
in the cytosol and, if this happens in neurons, it can lead to neu-
rodegenerative disease (Hara et al., 2006; Komatsu et al., 2006).
The ubiquitin-ligase CHIP is involved in the ubiquitylation of
these substrates and the chaperone BAG3, the ubiquitin-binding
protein sequestosome 1/p62 and its interacting protein Alfy are
involved in aggregate formation (Simonsen et al., 2004; Komatsu
et al., 2007; Gamerdinger et al., 2009; Arndt et al., 2010). Further-
more, p62 contains a LIR domain and links protein aggregates to
isolation membranes via LC3 (Bjorkoy et al., 2005; Pankiv et al.,
2007). In addition to p62, at least three other proteins have been
FIGURE 2 | Substrate recruitment into autophagosomes. Substrates are
imported into emerging autophagosomes (isolation membrane) via
anchoring to Atg8/LC3, which is covalently attached to the autophagosomal
membrane by the E3-like ligase Atg5/12/16L1. This anchoring occurs
through a LC3 interacting region (LIR), either via proteins that directly bind
to the cargo (LIR only, e.g., NIX for mitophagy) or via proteins that interact
with polyubiquitin tags on substrates, like Salmonella bacteria (green),
mitochondria (red), or protein aggregates (UBA+LIR, e.g., p62, NBR1,
NDP52, and optineurin for xeno- and mitophagy).
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identiﬁed that anchor poly-ubiquitylated substrates to LC3by con-
taining both ubiquitin-binding domains (UBA or UBZ) and LIRs.
These are NBR1, NDP52, and optineurin (Kirkin et al., 2009a;
Thurston et al., 2009; Wild et al., 2011), and might recruit dif-
ferent ubiquitylated substrates to autophagosomes. Moreover, the
versatility of substrate recruitment to macroautophagy could be
further enhanced by combining these different anchor proteins
with the extensive families of ubiquitin ligases. Along these lines
the ubiquitin-ligase Parkin has been shown to be recruited to
damaged mitochondria, for ubiquitylation and macroautophagic
degradation (Narendra et al., 2008, 2010; Dagda et al., 2009). In
addition, the multitude of proteins that bridge ubiquitin with LC3
allows their cooperation in substrate recruitment to autophago-
somes. Along these lines, NDP52 recruits in addition to LC3 the
Tank-binding kinase 1 (TBK1), which in turn phosphorylates
optineurin to bind with higher afﬁnity to LC3 (Thurston et al.,
2009; Wild et al., 2011). This cooperation for efﬁcient macroau-
tophagy occurs at distinct regions of pathogenic Salmonella bac-
teria, which have escaped to the cytosol. Furthermore, p62 binds
also to cytosolic Salmonella, but at separate regions of the bacteria
(Wild et al., 2011). Thus three anchor proteins seem to be involved
in xenophagy of this pathogen. Interestingly, no homologs of p62,
NBR1,NDP52, and optineurin have been identiﬁed in yeast (Kraft
et al., 2010). Therefore, ubiquitin-independent, but not ubiqui-
tin dependent substrate recruitment to autophagosomes seems to
be conserved between higher and lower eukaryotes. Accordingly,
ubiquitylation rather inhibits than accelerates macroautophagy of
ribosomes in yeast (Kraft et al., 2008). These recent studies provide
some information about the mechanistic underpinning of sub-
strate selection into autophagosomes, and suggest that in contrast
to previous assumptions macroautophagy is rarely non-selective.
INTRACELLULAR ANTIGEN PROCESSING VIA
MACROAUTOPHAGY
The immune system of higher eukaryotes uses the same degra-
dation machineries that are involved in organelle and protein
turnover for antigen processing. Accordingly, proteasomal prod-
ucts are presented on MHC class I molecules to CD8+ T cells,
and lysosomal degradation provides protein fragments for MHC
class II presentation to CD4+ T cells (Sijts and Kloetzel, 2011; Van
Den Hoorn et al., 2011). Therefore, it is probably not very surpris-
ing that autophagic pathways that lead to lysosomal degradation
of cytoplasmic constituents contribute to antigen processing for
MHC class II presentation (Figure 3). Indeed, 20–30% of nat-
ural MHC class II ligands are derived from cytosolic and nuclear
antigens (Marrack et al., 1993; Rammensee et al., 1999; Muntasell
et al., 2002). Starvation induced stimulation of macroautophagy
signiﬁcantly enhances MHC class II presentation of cytosolic and
nuclear antigens at the expense of membrane proteins (Dengjel
et al., 2005). Among the cytosolic proteins, whose peptides are
presented on MHC class II molecules, are also LC3 and Gabarap,
suggesting autophagosome fusionwithMHCclass II loading com-
partments (Dengjel et al., 2005; Suri et al., 2008). Indeed, 70–80%
of autophagosomes fusewithMIICs (Schmid et al., 2007). Further-
more, fusion of a model antigen to LC3 enhances its presentation
onMHCclass IImolecules up to 20-fold,while itsMHCclass I pre-
sentation remains largely unaffected (Schmid et al., 2007). Among
FIGURE 3 | Multivesicular bodies (MVBs) at the core of antigen
processing with the help of the macroautophagic molecular
machinery. Macroautophagy and/or its molecular machinery support
antigen processing via three main pathways. They transport cytoplasmic
material into MHC class II loading compartments (MIICs), assist
phagosome fusion with MIICs, and might allow for the release of antigen
for efﬁcient cross-presentation.
other tissues this frequent delivery of autophagosome cargo to
MIICs occurs also in thymic epithelial cells (Kasai et al., 2009).
The functional relevance of this cytoplasmic constituent deliv-
ery to MIICs in the thymus is underscored by the ﬁnding that
both positive and negative selection of CD4+, but not CD8+ T
cells are compromised in macroautophagy-deﬁcient thymii (Ned-
jic et al., 2008). Some, but not all CD4+ T cell receptors are not
positively selected byAtg5 deﬁcient thymic epithelial cells, suggest-
ing that some MHC class II ligands required for positive selection
get generated in a macroautophagy dependent pathway. Further-
more, MHC class II ligands for negative selection, eliminating
autoimmune T cells, are also dependent on macroautophagy. As
a result, the T cell repertoire selected through macroautophagy
negative thymii causes signs of autoimmunity, including severe
colitis (Nedjic et al., 2008). Along these lines, Atg16L1 mutations,
which presumably compromise macroautophagy, are enriched in
Crohn’s disease patients, who suffer from extreme colitis (Hampe
et al., 2007; Rioux et al., 2007). Interestingly, dendritic cells (DCs)
from these patients are deﬁcient in MHC class II up-regulation
upon maturation (Cooney et al., 2010). Modulation of this intra-
cellular antigen processing via macroautophagy inhibition with
a cell permeable spliceosomal U1-70K ribonucleoprotein peptide
seems also to ameliorate systemic autoimmunity, including lupus-
like symptoms in mice (Page et al., 2011). All these data suggest
that self-protein derived ligand processing and presentation on
MHC class II requires macroautophagy.
In addition, also pathogen derived antigens get processed via
macroautophagy for MHC class II presentation. The nuclear
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antigen 1 (EBNA1) of the Epstein Barr virus (EBV) was found
to be presented by EBV transformed B cells on MHC class II mol-
ecules to EBNA1 speciﬁc CD4+ T cells, which can be found in
most healthy carriers of this virus (Paludan et al., 2005; Leung
et al., 2010). The nuclear localization of this protein limits access
to macroautophagic processing for MHC class II presentation,
but nevertheless sensitizes EBV transformed B cells to recognition
by some EBNA1 speciﬁc CD4+ T cells. Similarly, some bacter-
ial antigens that escape after endocytosis or are injected into the
cytosol via secretion systems, can be processed for MHC class II
presentation via macroautophagy. This applies to the mycobac-
terial Ag85B antigen, which is more efﬁciently presented by DCs
after rapamycin induced macroautophagy up-regulation (Jagan-
nath et al., 2009). These DCs are then more potent in inducing
protective immune responses via vaccination. Furthermore, outer
proteins of Yersinia, which are injected into the cytosol by the
bacterial pathogen, are presented on MHC class II molecules
and this presentation is sensitive to pharmacological inhibition
of macroautophagy (Russmann et al., 2010). Additional evidence
for intracellular antigen processing for MHC class II presenta-
tion by infected cells comes from herpes simplex virus (HSV)
infection. HSV encodes with ICP34.5 a gene product that inter-
feres with macroautophagy (Orvedahl et al., 2007). Interestingly,
infection with HSV carrying mutant ICP34.5, which no longer
inhibits macroautophagy, is more rapidly controlled with elevated
CD4+ T cell expansion (Leib et al., 2009). Accordingly, HSV anti-
gens are more efﬁciently presented on MHC class II molecules
after infection with virus lacking the macroautophagy compro-
mising domain in ICP34.5. Along the same lines, HSV infection
is less well controlled in mice with macroautophagy deﬁciency
in DCs due to an inefﬁcient CD4+ T cell expansion (Lee et al.,
2010). These studies suggest that intracellular antigen processing
via macroautophagy can lead to MHC class II presentation to
CD4+ T cells.
In addition, one report exists that suggests that macroau-
tophagy can also assist intracellular antigen processing for MHC
class I presentation (English et al., 2009).
EXTRACELLULAR ANTIGEN PROCESSING VIA
MACROAUTOPHAGY
However, in recent years it has become apparent that also extra-
cellular antigen processing is affected by macroautophagy. Indeed,
the in vivo phenotype of diminished HSV speciﬁc CD4+ T cell
priming after infection of mice with macroautophagy-deﬁcient
DCs was accompanied by decreased MHC class II presentation
of extracellular antigen after endocytosis (Lee et al., 2010). In
these Atg5 deﬁcient DCs phagosomes did not efﬁciently fuse with
lysosomes, and thus did not sufﬁciently recruit hydrolases for
the degradation of the endocytosed cargo for processing toward
MHC class II presentation (Figure 3). Similarly, siRNA mediated
silencing of Atg8/LC3 compromises extracellular HIV p24 pro-
cessing for MHC class II presentation to CD4+ T cells (Blanchet
et al., 2010). These authors suggested that macroautophagy is
required to efﬁciently target endocytosed antigen to so-called
immunoamphisomes, in which MHC class II molecules could be
preferentially loaded. This defect in extracellular antigen process-
ing bymacroautophagy-deﬁcientDCs has been observed in a third
system. Salmonella antigen presentation on MHC class II mole-
cules andMHCclass II up-regulation duringmaturation of DCs in
general was macroautophagy dependent after nucleotide-binding
oligomerization domain-containing 2 (NOD2) receptors were
stimulated (Cooney et al., 2010). Interestingly, the Atg16L1 muta-
tion associatedwithCrohn’s disease also conferred this diminished
antigen processing for MHC class II presentation to DCs. These
data suggest that macroautophagy or its molecular machinery
contributes to efﬁcient delivery of phagosomes to lysosomes for
extracellular antigen processing. However, the mechanism of this
phagocytosis assistance by Atgs remains obscure.
The two main hypothesis that have been put forward to explain
enhanced phagosome processing with the help of the macroau-
tophagic machinery are amphisome formation prior to lysosome
fusion and recruitment of parts of the macroautophagic machin-
ery to the phagosomal membrane for enhanced fusion with
lysosomes. Along the lines of the ﬁrst hypothesis, NOD1 and 2
stimulation was suggested to recruit Atg16L1 directly to the site of
bacterial entry for rapid amphisome formation and degradation
of the invading pathogen (Travassos et al., 2010). Again mutant
Atg16L1, as present in Crohn’s disease patients, is not capable
to localize to sites of Shigella entry. In addition, reactive oxygen
species (ROS) and diacylglycerol production at the phagosome
membrane was proposed to promote engulfment of phagosomes
by autophagosomes or amphisome formation after fusion of these
two vesicular compartments (Huang et al., 2009; Shahnazari et al.,
2010). ROS was directly produced at the phagosome by NADPH
oxidases for this function. These signaling events at the phago-
somes were required for efﬁcient Salmonella degradation. As an
alternative for phagosome fusion with autophagosomes for more
efﬁcient delivery of endocytosed cargo via amphisomes, direct
coupling of the macroautophagic machinery, namely Atg8/LC3,
to the phagosome membrane was proposed (Sanjuan et al., 2007).
This Atg8/LC3 recruitment occurred only on phagosomes con-
taining toll-like receptor (TLR) ligands, primarily TLR2 and 4
agonists. It enhanced phagosome fusion with lysosomes. This
study tried to exclude amphisome formation by documenting
that the respective phagosomes were surrounded by a single
membrane, which did not contain any ER markers. However,
autophagosome membranes can be recruited from Golgi, mito-
chondria and plasma membrane in addition to the ER (Tooze and
Yoshimori, 2010) and amphisomes like MVBs are expected to be
surrounded by only one membrane with additional intravesicu-
lar membranes. Thus, this study could not entirely exclude that
the observed Atg8/LC3 recruitment is still due to autophagosome
formation, but if Atg8/LC3 would be directly coupled to phago-
somes it could assist enhanced membrane fusion with lysosomes
(Nakatogawa et al., 2007). The signaling downstream of TLRs
that would mediate this Atg8/LC3 recruitment and the function
of enhanced phagosome fusion with lysosomes via this mecha-
nism for antigen processing toward MHC presentation, however,
remains unclear and requires further investigation. Thus, extra-
cellular antigen processing for MHC class II, but not class I is
enhanced by macroautophagy, probably via promoting more efﬁ-
cient fusion of phagosomes with lysosomes. However, the mech-
anism, by which the macroautophagic machinery achieves this,
remains unclear.
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SUPPORT OF CROSS-PRESENTATION BY
MACROAUTOPHAGY
In contrast to the role of themacroautophagymachinery for extra-
cellular antigen presentation on MHC class II molecules in antigen
presenting cells, autophagosomes seem to play a role for intracel-
lular antigen release by the antigen donor cell that favors cross-
presentation on MHC class I molecules. Both cross-presentation
of viral and tumor antigens seems to beneﬁt from intact macroau-
tophagy in the infected or transformed cells, respectively (Li
et al., 2008; Uhl et al., 2009). Interestingly, the viral antigens that
were investigated were from inﬂuenza A virus, which stabilizes
autophagosomes by preventing their fusion with lysosomes (Gan-
nage et al., 2009). Along these lines, autophagosomes were found
to be efﬁcient antigen carriers, when isolated from tumor cells
(Li et al., 2008). Therefore, autophagosome stabilization might
enhance the ability of antigen donor cells to provide antigen
for efﬁcient cross-presentation. But how do autophagosomes and
their content exit cells for cross-presentation? One possibility
might be macroautophagy dependent unconventional secretion
of proteins. In yeast, macroautophagy dependent secretion of the
acyl coenzyme A-binding protein (ACBP) occurs signal sequence
independent and requires macroautophagy (Duran et al., 2010;
Manjithaya et al., 2010). Interestingly, this process requires com-
ponents of vesicular fusion with the plasma membrane, but not
fusion with the vacuole, yeast’s lysosome equivalent. It is tempting
to speculate that antigen can be secreted by an unconventional
pathway from MVBs that receive input from autophagosomes.
In this case, inner autophagosomal membranes, which become
intravesicular membranes of MVBs might exit cells as exosomes
(Figure 3). Exosomes, only one of many antigen transfer vectors,
have been reported to be highly immunogenic (Thery et al., 2009).
Along these lines, drusen, extracellular amorphous deposits in
Age-related macular degeneration, were found to be positive for
both exosome and macroautophagy markers (Wang et al., 2009).
The source of these drusen, the retinal pigment epithelium was
found to display markers of elevated macroautophagy, diminished
lysosomal activity and increased exocytosis, which might lead
to enhanced secretion of inner autophagic membranes as exo-
somes. Thus autophagosomes might package antigens efﬁciently
for cross-presentation on MHC class I molecules.
CONCLUSION
In this review, I have discussed three pathways, by which macroau-
tophagy can assist in antigen processing for MHC presentation to
T cells. Two affect intracellular antigens, and deliver those either
directly for MHC class II presentation by the antigen expressing
cells or packages them for cross-presentation by MHC molecules
of bystander cells. The third affects processing of endocytosed
extracellular antigens, promoting phagosome fusion with lyso-
somes for antigen processing toward MHC class II presentation
by phagocytes. Interestingly, in the two antigen processing path-
ways for MHC class II presentation the lysosome targeting abilities
of the macroautophagic machinery are utilized, while for cross-
presentation prevention of lysosome fusion and redirection of
autophagosome content to exocytosis might be required. At the
core of all these diverse pathways, MVBs might play a key role,
both as MIICs and sources of unconventional secretion. Thus, all
these antigen processing pathways supported by macroautophagy
might use the macroautophagic machinery to efﬁciently gener-
ate these vesicles and transport cargo into them. Therefore, a
more detailed analysis of how the macroautophagic machinery
contributes to MVB generation might proof useful for a better
understanding of antigen processing for MHC presentation via
macroautophagy.
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